Bhowmick, Tanaya; Canton, Rafael; Pea, Federico; Quevedo, Juan; Santerre Henriksen, Anne; Timsit, Jean-François; Kaye, Keith S, Cefepime-enmetazobactam: first approved cefepime-β- lactamase inhibitor combination for multi-drug resistant Enterobacterales, «FUTURE MICROBIOLOGY», in corso di stampa, Online ahead of print, pp. 1 - 10 [articolo]Open Access
Gatti, Milo; De Paola, Riccardo; Rinaldi, Matteo; Laici, Cristiana; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, ARC in Critical Ill OLT Recipients: True Prevalence, Risk Factors, and Impact on Early Aggressive PK/PD Target Non‐Attainment of CI Beta‐Lactam Therapy for Posttransplant Gram‐Negative Infections, «TRANSPLANT INFECTIOUS DISEASE», 2026, 10.1111/tid.70237, pp. 1 - 9 [articolo]
Trozzi, Ilaria; Giorgi, Beatrice; De Paola, Riccardo; Gatti, Milo; Pea, Federico, Accurate and Sensitive UHPLC–Tandem Mass Spectrometry Sequential Methods for Therapeutic Drug Monitoring of Aztreonam/Avibactam in Human Plasma, «PHARMACEUTICS», 2026, 18, Article number: 377, pp. 1 - 15 [articolo]Open Access
Gatti, Milo; Bonazzetti, Cecilia; Secci, Benedetta; Giorgi, Beatrice; Rinaldi, Matteo; Cojutti, Pier Giorgio; Ambretti, Simone; Siniscalchi, Antonio; Tonetti, Tommaso; Viale, Pierluigi; Pea, Federico, Aggressive joint pharmacokinetic/pharmacodynamic target attainment of TDM-guided continuous infusion meropenem-vaborbactam monotherapy: a valuable strategy for maximizing the microbiological outcome of documented KPC-producing Enterobacterales infections?, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2026, 10.1016/j.ijantimicag.2026.107811, pp. 1 - 10 [articolo]
Gatti, Milo; Rinaldi, Matteo; Laici, Cristiana; Ambretti, Simone; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime–avibactam in a case series of orthotopic liver transplant recipients, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2026, 81, Article number: dkag009, pp. 1 - 5 [articolo]Open Access
Gatti, Milo; De Paola, Riccardo; Giorgi, Beatrice; Pea, Federico, Comparison of ceftolozane-tazobactam and ceftazidime-avibactam in the treatment of MDR/DTR
Pseudomonas aeruginosa
infections: a systematic review and meta-analysis, «CLINICAL INFECTIOUS DISEASES», 2026, 10.1093/cid/ciag194, pp. 1 - 23 [articolo]
Soriano, Alex; Tascini, Carlo; Falcone, Marco; Morata, Laura; Bongiovanni, Marco; Pea, Federico; Viale, Pierluigi, Evaluating oritavancin for Gram-positive infections: a systematic review of on-label and off-label use, «DRUGS IN CONTEXT», 2026, 15, Article number: 202594, pp. 1 - 18 [articolo]Open Access
Tascini, Carlo; Bulfoni, Michela; Giuliano, Simone; Cojutti, Piergiorgio; Cotrufo, Marco; Lombardo, Cinzia; Curcio, Francesco; Pea, Federico; Moreal, Chiara; Gaibani, Paolo, Genome Sequence of a Methicillin-Resistant Staphylococcus epidermidis (MRSE) Resistant to Dalbavancin and Teicoplanin isolated in Italy, 2023, «JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE», 2026, 10.1016/j.jgar.2026.05.006, pp. 1 - 5 [articolo]
Riccardi, Alessandro; De Iaco, Fabio; Del Giudice, Elena; Guarino, Mario; Parri, Niccolò; Pea, Federico; Cocorocchio, Antonella; Serra, Sossio, Management of Mild to Moderate Pain from Triage to Discharge in the Emergency Department: A Multidisciplinary Delphi Consensus from the Italian Society of Emergency Medicine (SIMEU), «JOURNAL OF CLINICAL MEDICINE», 2026, 10.3390/jcm15093230, pp. 1 - 11 [articolo]
Cojutti, Pier Giorgio; Pascale, Renato; Grechi, Andrea; Ambretti, Simone; Viale, Pierluigi; Pea, Federico, Pharmacokinetic/Pharmacodynamic Analysis of High-Dose Daptomycin in Combination with Continuous Infusion Ceftobiprole in a Case Series of Documented Staphylococcal Bacteremia or Endocarditis: Is There Any Room for TDM-Guided Dosing Reduction?, «ANTIBIOTICS», 2026, 15, Article number: 315, pp. 1 - 15 [articolo]Open Access
Gatti, Milo; Pea, Federico, Pharmacological approaches to overcome antimicrobial resistance to novel beta-lactams in MDR Gram-negative bacterial infections: Current practice and future directions, «EXPERT OPINION ON PHARMACOTHERAPY», 2026, 10.1080/14656566.2026.2651279, pp. 1 - 19 [articolo]
Gatti, Milo; Pea, Federico, Raising the Bar of PK/PD Target Attainment of Beta-Lactams in Daily Clinical Practice: An Effective Strategy to Overcome Resistance Development to Novel Beta-Lactams?, «INFECTIOUS DISEASE REPORTS», 2026, 18, Article number: 3, pp. 1 - 4 [articolo]Open Access
Gatti, Milo; Pea, Federico, Re: ‘Pharmacokinetics, target attainment and outcomes of piperacillin/tazobactam in critically ill patients receiving continuous infusion with therapeutic drug monitoring: a retrospective analysis’ by Chiriac et al, «CLINICAL MICROBIOLOGY AND INFECTION», 2026, 10.1016/j.cmi.2026.05.006, pp. 1 - 2 [replica/breve intervento]
Gatti, Milo; Pea, Federico, Real-World Evidence and Multidrug Resistant Infections: How Can We Leverage RWE to Improve Patient Outcome with the Novel Beta-Lactam and Beta-Lactam/Beta-Lactamase Inhibitor Combinations, «INFECTION AND DRUG RESISTANCE», 2026, 19, pp. 1 - 23 [articolo]Open Access
Trozzi, Ilaria; Giorgi, Beatrice; De Paola, Riccardo; Gatti, Milo; Pea, Federico, Two Comprehensive Liquid Chromatography High-Resolution Mass Spectrometry (UPLC-MS/MS) Multi-Methods for Real-Time Therapeutic Drug Monitoring (TDM) of Five Novel Beta-Lactams and of Fosfomycin Administered by Continuous Infusion, «PHARMACEUTICS», 2026, 18, Article number: 91, pp. 1 - 20 [articolo]Open Access
